Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 71

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 71
---
 |     | Responsible use of shares in our long-term incentive program                   |     | X |     | Margin accounts, hedging, pledging, derivatives or short sale transactions in our stock |
| ü |     | Annually assesses compensation risk                                            |     | X |     | Repricing stock options without stockholder approval                                    |
| ü |     | Annual say on pay                                                              |     |   |     |                                                                                         |

#### Recent “Say-on-Pay” Vote
At our June 2024 annual meeting of stockholders, we held a nonbinding, stockholder advisory vote to approve the compensation of our NEOs, commonly referred to as a “say-on-pay” vote. We received favorable support with over 95% of stockholder votes cast approving the proposal. Our Compensation Committee appreciates this strong support and believes it reflects the efforts to properly align pay with performance while also aligning management and stockholder interests. The Compensation Committee considers the outcome of these voting decisions and feedback received from stockholders when considering future compensation decisions. Stockholders have the opportunity to participate annually in a say-on-pay vote during each Annual Meeting. We value the opinions of our stockholders.

#### Compensation Philosophy and Objectives
Our executive compensation program is overseen and administered by the Compensation Committee, of which each member is an independent member of our Board of Directors as defined in the listing rules.

The guiding principle in the development of our compensation strategy is to create and promote a pay-for-performance culture, where contributions to enhancing stockholder value have the potential to be matched with appropriate financial rewards. The objectives of our compensation program are to:

#### •

#### attract highly skilled employees;
• motivate successful execution of our corporate objectives;

• ensure that, consistent with our pay for performance objectives, broad-based compensation programs are aligned with company objectives that when achieved will promote an increase in the value of the Company for our stockholders; and

#### •

#### ensure retention of key staff.
| 2025 Proxy Statement |     | 53 |

TABLE OF CONTENTS

Our executive compensation program consists primarily of salary, incentive cash and equity compensation, the latter of which, due to a limited number of shares available under the 2020 Plan, and in order to deliver predictable value to the Company’s employees, consisted solely of RSUs in 2024. Likewise, we maintain compensation programs that cover employees to align with the variable cash and equity pay component already provided to executive-level employees. We typically make new equity award grants annually and consider adjustments to the components